mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.4 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.23 |
0.4 |